Vir Biotechnology, Inc. (VIR)
11.30
-0.45
(-3.83%)
USD |
NASDAQ |
Oct 30, 16:00
11.46
+0.16
(+1.42%)
After-Hours: 20:00
Vir Biotechnology 30-Day Average Daily Volume : 1.835M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.835M |
| October 29, 2026 | 2.026M |
| October 28, 2026 | 2.039M |
| October 27, 2026 | 2.057M |
| October 26, 2026 | 2.067M |
| October 23, 2026 | 2.075M |
| October 22, 2026 | 2.088M |
| October 21, 2026 | 2.117M |
| October 20, 2026 | 2.144M |
| October 19, 2026 | 2.153M |
| October 16, 2026 | 2.148M |
| October 15, 2026 | 2.176M |
| October 14, 2026 | 2.229M |
| October 13, 2026 | 2.229M |
| October 12, 2026 | 2.272M |
| October 09, 2026 | 2.296M |
| October 08, 2026 | 2.289M |
| October 07, 2026 | 2.261M |
| October 06, 2026 | 2.241M |
| October 05, 2026 | 2.213M |
| October 02, 2026 | 2.167M |
| October 01, 2026 | 2.130M |
| September 30, 2026 | 2.113M |
| September 29, 2026 | 2.105M |
| September 28, 2026 | 2.101M |
| Date | Value |
|---|---|
| September 25, 2026 | 2.089M |
| September 24, 2026 | 2.093M |
| September 23, 2026 | 2.056M |
| September 22, 2026 | 2.040M |
| September 21, 2026 | 2.028M |
| September 18, 2026 | 2.035M |
| September 17, 2026 | 1.888M |
| September 16, 2026 | 1.877M |
| September 15, 2026 | 1.864M |
| September 14, 2026 | 1.829M |
| September 11, 2026 | 1.805M |
| September 10, 2026 | 1.776M |
| September 09, 2026 | 1.761M |
| September 08, 2026 | 1.743M |
| September 04, 2026 | 1.745M |
| September 03, 2026 | 1.778M |
| September 02, 2026 | 1.743M |
| September 01, 2026 | 1.691M |
| August 31, 2026 | 1.656M |
| August 28, 2026 | 1.604M |
| August 27, 2026 | 1.601M |
| August 26, 2026 | 1.608M |
| August 25, 2026 | 1.574M |
| August 24, 2026 | 1.531M |
| August 21, 2026 | 1.537M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Moderna, Inc. | 18.56M |
| Vaxcyte, Inc. | 3.169M |
| Caribou Biosciences, Inc. | 4.225M |
| Arrowhead Pharmaceuticals, Inc. | 1.853M |
| Oncolytics Biotech, Inc. | 1.292M |